Athanase Innovation AB (ATIN) Stock Statistics & Valuation Metrics

Athanase Innovation AB has a market cap or net worth of kr268.24M. The enterprise value is kr12.76M.

Athanase Innovation AB has 19,297,642 shares outstanding. The number of shares has decreased by -2.65% in one year.

Athanase Innovation AB’s return on equity (ROE) is -0.13 and return on invested capital (ROIC) is -19.04%.

The current PE Ratio of Athanase Innovation AB is ―. Athanase Innovation AB’s PEG ratio is -0.02.

In the last 12 months, Athanase Innovation AB had revenue of 36.86M and earned -57.62M in profits. Earnings per share was -2.99.

In the last 12 months, operating cash flow was -57.46M and capital expenditures 14.79M, giving a free cash flow of -41.18M billion.

Athanase Innovation AB pays an annual dividend of kr289.504, resulting in a dividend yield of ―

Athanase Innovation AB upcoming earnings date is May 12, 2026, Before Open (Confirmed).

Athanase Innovation AB as a current ratio of 5.11, with Debt / Equity ratio of 0.00%

In the past 12 months, Athanase Innovation AB has paid 331.00K in taxes.

Athanase Innovation AB EV to EBITDA ratio is -1.52, with an EV/FCF ratio of 0.00.

Athanase Innovation AB has kr255.49M in cash and marketable securities with kr0.00 in debt, giving a net cash position of kr255.49M billion.

Gross margin is -100.07%, with operating margin of -220.88%, and net profit margin of -156.33%.

The average price target for Athanase Innovation AB is ―, which is 11.43% higher than the current price. The consensus rating is ―